000			02210 a2200589 4500
005			20250518053539.0
264		0	_c20200330
008			202003s 0 0 eng d
022			_a1522-1547
024	7		_a10.1152/ajpgi.00061.2019 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlbadrani, Muayad
245	0	0	_aExogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21. _h[electronic resource]
260			_bAmerican journal of physiology. Gastrointestinal and liver physiology _c10 2019
300			_aG408-G428 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntigens, CD _xbiosynthesis
650	0	4	_aAntigens, Differentiation, Myelomonocytic _xbiosynthesis
650	0	4	_aCytokines _xmetabolism
650	0	4	_aEnzyme Inhibitors _xtoxicity
650	0	4	_aHepatic Stellate Cells _xdrug effects
650	0	4	_aKupffer Cells _xdrug effects
650	0	4	_aLiver Cirrhosis _xchemically induced
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aMicroRNAs _xgenetics
650	0	4	_aMicrocystins _xtoxicity
650	0	4	_aNADPH Oxidase 2 _xgenetics
650	0	4	_aNADPH Oxidases _xmetabolism
650	0	4	_aNon-alcoholic Fatty Liver Disease _xchemically induced
650	0	4	_aPeroxynitrous Acid _xmetabolism
650	0	4	_aProtein Phosphatase 2 _xantagonists & inhibitors
700	1		_aSeth, Ratanesh K
700	1		_aSarkar, Sutapa
700	1		_aKimono, Diana
700	1		_aMondal, Ayan
700	1		_aBose, Dipro
700	1		_aPorter, Dwayne E
700	1		_aScott, Geoff I
700	1		_aBrooks, Bryan
700	1		_aRaychoudhury, Samir
700	1		_aNagarkatti, Mitzi
700	1		_aNagarkatti, Prakash
700	1		_aJule, Yvon
700	1		_aDiehl, Anna Mae
700	1		_aChatterjee, Saurabh
773	0		_tAmerican journal of physiology. Gastrointestinal and liver physiology _gvol. 317 _gno. 4 _gp. G408-G428
856	4	0	_uhttps://doi.org/10.1152/ajpgi.00061.2019 _zAvailable from publisher's website
999			_c29987023 _d29987023